Connect with us

Hi, what are you looking for?

Health Care Sector

Over 45 Countries Request Cuba’s Interferon Alpha 2B

Cuba's Interferon Alpha 2B, the only drug currently available to combat COVID19 is in high demand. Photo courtesy: Twitter: Cuba

More than 45 countries have requested Cuba’s Interferon Alpha 2B Recombinant, the only drug currently available to combat COVID19 (coronavirus). The drug is manufactured by the Center for Genetic Engineering and Biotechnology (CIGB) under the brand name Heberon Alfa R.

Without any other alternatives on the horizon, other nations are seeking to incorporate Interferon Alpha 2B into their treatment protocol after the positive results observed in China.

Interferon Alpha 2 generates an antiviral mechanism that relates to the body’s immune system. It acts with virus-like particles to stimulate the immune system. The vaccine is applied nasally.

Cuba is currently researching and testing 22 other medicines to combat the COVID-19.

Advertisement. Scroll to continue reading.

A meeting held recently between BioCubaFarma and researchers verified the progress made in preliminary clinical trials of the vaccine. It will be incorporated into current treatment protocols.

Cuba is currently using other drugs in addition to Interferon Alfa 2 B to combat COVID-19. These include Oseltamivir, a selective inhibitor of flu virus neuraminidases, and Kaletra, an antiretroviral that has been successful globally in healing infected persons.

A team of researchers at the Ministry of Health (MINSAP) are watching new developments and testing treatments that have yielded results in other countries.

Cuba continues to supply its own health system with the drugs necessary to treat infected patients. The President of BioCubaPharma said at a press conference it has “all the capacities to supply this antiviral to the National Health System and respond to requests, without putting at risk the amounts required by the country.”

Advertisement. Scroll to continue reading.

Related News:

Health Care Sector

Cuba and China are working together to develop a new vaccine called the PanCorona which will be effective against new variants of COVID-19. The...

Health Care Sector

Cuba has registered its fourth COVID-19 vaccine to undergo clinical trials. The two new vaccines are known as the Mambisa (CIGB 669) and Abdala...

Health Care Sector

His Excellency Ambassador Antony Stokes LVO attended a presentation at the Center for Genetic Engineering and Biotechnology (CIGB) to learn of the progress of...

Health Care Sector

The president of the business group BioCubaFarma, Eduardo Martinez, announced that by the year 2021 all Cubans will be vaccinated against COVID-19. On October...

error: This content is copyright protected.